SETD2 and chronic myelogenous leukemia, BCR-ABL1 positive: Taken together, these findings indicate that in advanced‐phase CML a functional SETD2 protein is produced, but it undergoes hyper‐ubiquitination and rapid proteasome mediated‐degradation which ultimately results in H3K36me3 deficiency.